蓝帆医疗：9月4日召开董事会会议

Group 1 - The core point of the article is that Bluestar Medical (SZ 002382) held its 29th meeting of the sixth board of directors on September 4, 2025, via telecommunication voting, where it reviewed the proposal for the fourth extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, Bluestar Medical's revenue composition was as follows: rubber and plastic products accounted for 70.08%, specialized equipment manufacturing accounted for 24.88%, other manufacturing accounted for 3.72%, and other businesses accounted for 1.32% [1] - As of the time of reporting, Bluestar Medical's market capitalization was 5.9 billion yuan [1]